Rank | Gene Set | Z-score |
---|---|---|
1 | creatine metabolic process (GO:0006600) | 5.55752895 |
2 | actomyosin structure organization (GO:0031032) | 5.19202350 |
3 | response to muscle activity (GO:0014850) | 5.04271747 |
4 | NADH metabolic process (GO:0006734) | 4.87428418 |
5 | response to inactivity (GO:0014854) | 4.85178536 |
6 | muscle contraction (GO:0006936) | 4.81250463 |
7 | cardiac muscle hypertrophy (GO:0003300) | 4.66585509 |
8 | heart process (GO:0003015) | 4.51426302 |
9 | heart contraction (GO:0060047) | 4.51426302 |
10 | striated muscle hypertrophy (GO:0014897) | 4.44463073 |
11 | skeletal muscle fiber development (GO:0048741) | 4.43741830 |
12 | omega-hydroxylase P450 pathway (GO:0097267) | 4.32768592 |
13 | muscle system process (GO:0003012) | 4.31456496 |
14 | striated muscle atrophy (GO:0014891) | 4.15939541 |
15 | muscle tissue morphogenesis (GO:0060415) | 4.13139049 |
16 | myotube cell development (GO:0014904) | 4.13009321 |
17 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.12315081 |
18 | striated muscle adaptation (GO:0014888) | 4.11597489 |
19 | muscle hypertrophy (GO:0014896) | 3.94063602 |
20 | skeletal muscle tissue development (GO:0007519) | 3.76856035 |
21 | muscle atrophy (GO:0014889) | 3.70725385 |
22 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.69798814 |
23 | glucan biosynthetic process (GO:0009250) | 3.67828459 |
24 | glycogen biosynthetic process (GO:0005978) | 3.67828459 |
25 | muscle fiber development (GO:0048747) | 3.66076559 |
26 | tricarboxylic acid cycle (GO:0006099) | 3.63656125 |
27 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.59721442 |
28 | neuronal action potential propagation (GO:0019227) | 3.54006216 |
29 | regulation of the force of heart contraction (GO:0002026) | 3.53320492 |
30 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.51323055 |
31 | regulation of cell communication by electrical coupling (GO:0010649) | 3.50471782 |
32 | 2-oxoglutarate metabolic process (GO:0006103) | 3.45021160 |
33 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.41261641 |
34 | carnitine shuttle (GO:0006853) | 3.40674609 |
35 | muscle adaptation (GO:0043500) | 3.32295926 |
36 | plasma membrane repair (GO:0001778) | 3.30691930 |
37 | muscle cell cellular homeostasis (GO:0046716) | 3.30235519 |
38 | positive regulation of myotube differentiation (GO:0010831) | 3.29444483 |
39 | regulation of skeletal muscle contraction (GO:0014819) | 3.28041065 |
40 | cardiac muscle adaptation (GO:0014887) | 3.27781293 |
41 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.27781293 |
42 | muscle hypertrophy in response to stress (GO:0003299) | 3.27781293 |
43 | sperm motility (GO:0030317) | 3.22832535 |
44 | cardiac muscle cell development (GO:0055013) | 3.20882397 |
45 | muscle filament sliding (GO:0030049) | 3.19125069 |
46 | actin-myosin filament sliding (GO:0033275) | 3.19125069 |
47 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.17920121 |
48 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.17541187 |
49 | negative regulation of protein localization to cell surface (GO:2000009) | 3.16907547 |
50 | fructose metabolic process (GO:0006000) | 3.16652634 |
51 | skeletal muscle tissue regeneration (GO:0043403) | 3.16357972 |
52 | response to epinephrine (GO:0071871) | 3.15273200 |
53 | fatty acid transmembrane transport (GO:1902001) | 3.14560522 |
54 | carnitine transmembrane transport (GO:1902603) | 3.13681057 |
55 | glycogen metabolic process (GO:0005977) | 3.12895561 |
56 | muscle cell fate commitment (GO:0042693) | 3.12804245 |
57 | acrosome reaction (GO:0007340) | 3.11107209 |
58 | striated muscle cell development (GO:0055002) | 3.10476693 |
59 | cellular response to epinephrine stimulus (GO:0071872) | 3.10370261 |
60 | gluconeogenesis (GO:0006094) | 3.07086687 |
61 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.06173771 |
62 | cellular glucan metabolic process (GO:0006073) | 3.06067521 |
63 | glucan metabolic process (GO:0044042) | 3.06067521 |
64 | positive regulation of cation channel activity (GO:2001259) | 3.05909898 |
65 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.04113179 |
66 | oxaloacetate metabolic process (GO:0006107) | 3.02354101 |
67 | carnitine transport (GO:0015879) | 3.01679157 |
68 | amino-acid betaine transport (GO:0015838) | 3.01679157 |
69 | regulation of muscle system process (GO:0090257) | 2.96365320 |
70 | relaxation of muscle (GO:0090075) | 2.95159886 |
71 | cardiac cell development (GO:0055006) | 2.93297680 |
72 | regulation of ATPase activity (GO:0043462) | 2.91483183 |
73 | regulation of ATP catabolic process (GO:1903289) | 2.91483183 |
74 | muscle organ development (GO:0007517) | 2.89440220 |
75 | adult heart development (GO:0007512) | 2.88719598 |
76 | glycogen catabolic process (GO:0005980) | 2.88456181 |
77 | muscle structure development (GO:0061061) | 2.87424199 |
78 | macroautophagy (GO:0016236) | 2.87033207 |
79 | regulation of relaxation of muscle (GO:1901077) | 2.86175947 |
80 | myoblast fusion (GO:0007520) | 2.85849972 |
81 | synaptic vesicle maturation (GO:0016188) | 2.85501250 |
82 | acrosome assembly (GO:0001675) | 2.77170572 |
83 | regulation of actin filament-based movement (GO:1903115) | 2.75106432 |
84 | membrane depolarization during action potential (GO:0086010) | 2.74018664 |
85 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.73919819 |
86 | skeletal muscle contraction (GO:0003009) | 2.73361421 |
87 | glucan catabolic process (GO:0009251) | 2.69191772 |
88 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.67972186 |
89 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.67661406 |
90 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.67435554 |
91 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.67084937 |
92 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.66792726 |
93 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.65583708 |
94 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.65506057 |
95 | actin-mediated cell contraction (GO:0070252) | 2.65119687 |
96 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.64292891 |
97 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.64292891 |
98 | activation of protein kinase A activity (GO:0034199) | 2.58843077 |
99 | myofibril assembly (GO:0030239) | 2.55090512 |
100 | presynaptic membrane assembly (GO:0097105) | 2.54997717 |
101 | cAMP catabolic process (GO:0006198) | 2.53396441 |
102 | skeletal muscle adaptation (GO:0043501) | 2.52059565 |
103 | detection of calcium ion (GO:0005513) | 2.49144044 |
104 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.46232360 |
105 | vocalization behavior (GO:0071625) | 2.45668796 |
106 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.45384249 |
107 | cell communication involved in cardiac conduction (GO:0086065) | 2.45222031 |
108 | calcium ion import (GO:0070509) | 2.44417915 |
109 | calcium ion-dependent exocytosis (GO:0017156) | 2.44384075 |
110 | cellular polysaccharide catabolic process (GO:0044247) | 2.43678196 |
111 | striated muscle contraction (GO:0006941) | 2.43222132 |
112 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.42622840 |
113 | plasma membrane fusion (GO:0045026) | 2.40638000 |
114 | sarcomere organization (GO:0045214) | 2.37833046 |
115 | regulation of ARF protein signal transduction (GO:0032012) | 2.37473108 |
116 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.35881947 |
117 | sperm capacitation (GO:0048240) | 2.33903732 |
118 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.32902283 |
119 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.31821659 |
120 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.30895769 |
121 | polysaccharide catabolic process (GO:0000272) | 2.30116741 |
122 | quaternary ammonium group transport (GO:0015697) | 2.30113508 |
123 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.29249889 |
124 | L-phenylalanine catabolic process (GO:0006559) | 2.28688623 |
125 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.28688623 |
126 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.28462445 |
127 | establishment of protein localization to Golgi (GO:0072600) | 2.28000080 |
128 | cell communication by electrical coupling (GO:0010644) | 2.27994593 |
129 | protein targeting to Golgi (GO:0000042) | 2.27481811 |
130 | cardiac muscle contraction (GO:0060048) | 2.26866891 |
131 | protein localization to synapse (GO:0035418) | 2.25613416 |
132 | postsynaptic membrane organization (GO:0001941) | 2.24277789 |
133 | urea cycle (GO:0000050) | 2.24069778 |
134 | urea metabolic process (GO:0019627) | 2.24069778 |
135 | cyclic nucleotide catabolic process (GO:0009214) | 2.23940189 |
136 | regulation of striated muscle contraction (GO:0006942) | 2.23717848 |
137 | cardiac myofibril assembly (GO:0055003) | 2.21699521 |
138 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.21341921 |
139 | negative regulation of inclusion body assembly (GO:0090084) | 2.20605014 |
140 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.20299517 |
141 | regulation of sequestering of triglyceride (GO:0010889) | 2.19569313 |
142 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.19067005 |
143 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.19067005 |
144 | cell wall macromolecule catabolic process (GO:0016998) | 2.17984416 |
145 | cell wall macromolecule metabolic process (GO:0044036) | 2.17984416 |
146 | multicellular organism reproduction (GO:0032504) | 2.17918893 |
147 | presynaptic membrane organization (GO:0097090) | 2.17836389 |
148 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.17725636 |
149 | regulation of membrane repolarization (GO:0060306) | 2.17289316 |
150 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.16807283 |
151 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.14968873 |
152 | regulation of cation channel activity (GO:2001257) | 2.13893781 |
153 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.13625554 |
154 | N-acetylneuraminate metabolic process (GO:0006054) | 2.13564215 |
155 | actin filament-based movement (GO:0030048) | 2.13175555 |
156 | locomotory exploration behavior (GO:0035641) | 2.11863615 |
157 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.09568536 |
158 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.08619769 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.46007622 |
2 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.06174400 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.06012269 |
4 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.91631773 |
5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.46230857 |
6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.46102158 |
7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.29054329 |
8 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.23126013 |
9 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.22927800 |
10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.20316108 |
11 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.18054429 |
12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.09132502 |
13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.07584362 |
14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.88511114 |
15 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.87086915 |
16 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.85771311 |
17 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.85156273 |
18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.81526513 |
19 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.81128452 |
20 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.81128452 |
21 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.79361859 |
22 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.78110742 |
23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.73560881 |
24 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.72439494 |
25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.69287511 |
26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.69093275 |
27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.66541936 |
28 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.60098307 |
29 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.59805391 |
30 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.58941340 |
31 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.58615565 |
32 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.55631309 |
33 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.55619140 |
34 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.54945264 |
35 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51927409 |
36 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.49413261 |
37 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.48204191 |
38 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.47868442 |
39 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.47631912 |
40 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.46002099 |
41 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.44829361 |
42 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.44479258 |
43 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.44134056 |
44 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.43653719 |
45 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.43466399 |
46 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.42847541 |
47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.40799856 |
48 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.39046185 |
49 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.37442687 |
50 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.35356588 |
51 | GATA1_19941826_ChIP-Seq_K562_Human | 1.34687844 |
52 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.34099779 |
53 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.32277148 |
54 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.31641570 |
55 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.30263170 |
56 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29593257 |
57 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.23953007 |
58 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.22853842 |
59 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.22528575 |
60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22281566 |
61 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.22061242 |
62 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.22007984 |
63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.22001935 |
64 | CJUN_26792858_Chip-Seq_BT549_Human | 1.21578314 |
65 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.21409669 |
66 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.19950731 |
67 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19593892 |
68 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18204546 |
69 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.17253237 |
70 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.16696653 |
71 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.16675518 |
72 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.15918318 |
73 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15725611 |
74 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.15643360 |
75 | GATA2_19941826_ChIP-Seq_K562_Human | 1.15497265 |
76 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.14590415 |
77 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14402740 |
78 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11129960 |
79 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.08837708 |
80 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.08487270 |
81 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.08166332 |
82 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.08164818 |
83 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.07613411 |
84 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07027025 |
85 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06716900 |
86 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.06276970 |
87 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.06113533 |
88 | STAT3_23295773_ChIP-Seq_U87_Human | 1.05930211 |
89 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.03891524 |
90 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.03631389 |
91 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.03561418 |
92 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.03181784 |
93 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.01937900 |
94 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.01452806 |
95 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.01023338 |
96 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00877121 |
97 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00198884 |
98 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.99425680 |
99 | AR_25329375_ChIP-Seq_VCAP_Human | 0.98642157 |
100 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.98129123 |
101 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.97905942 |
102 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.97884662 |
103 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.97426584 |
104 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96587389 |
105 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95891636 |
106 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94974402 |
107 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.94912703 |
108 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.94638808 |
109 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.94638808 |
110 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.94255498 |
111 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.94137751 |
112 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.94131364 |
113 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.93937625 |
114 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.93937625 |
115 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93903601 |
116 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93376883 |
117 | KDM2B_26808549_Chip-Seq_REH_Human | 0.92938273 |
118 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.92883924 |
119 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.92241014 |
120 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92115616 |
121 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91535351 |
122 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90838843 |
123 | AR_19668381_ChIP-Seq_PC3_Human | 0.90562740 |
124 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90480318 |
125 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.90468227 |
126 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.90051425 |
127 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.89857853 |
128 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89175850 |
129 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.88884171 |
130 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.88700848 |
131 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.88652906 |
132 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.87833784 |
133 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.87512736 |
134 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.87512736 |
135 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.87261561 |
136 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.86023261 |
137 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.85836229 |
138 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.85168925 |
139 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.84820107 |
140 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.84780429 |
141 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.84218233 |
142 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84146443 |
143 | P300_19829295_ChIP-Seq_ESCs_Human | 0.83463444 |
144 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.83335463 |
145 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.83282935 |
146 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.83269395 |
147 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.83046504 |
148 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.83046504 |
149 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82831615 |
150 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.82829518 |
151 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.82819713 |
152 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.82809977 |
153 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.82753373 |
154 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81542500 |
155 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79288866 |
156 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.78232413 |
157 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.77411608 |
158 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.76508651 |
159 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.76289578 |
160 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.76079211 |
161 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.75417316 |
162 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.74634361 |
163 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.74584884 |
164 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.72773100 |
165 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.72654174 |
166 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.72491153 |
167 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.72076136 |
168 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71412909 |
169 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.70621570 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003646_muscle_fatigue | 3.74163151 |
2 | MP0002837_dystrophic_cardiac_calcinosis | 3.62512391 |
3 | MP0004145_abnormal_muscle_electrophysio | 3.60075058 |
4 | MP0000751_myopathy | 3.42132968 |
5 | MP0005451_abnormal_body_composition | 3.38121520 |
6 | MP0000749_muscle_degeneration | 3.18664388 |
7 | MP0005410_abnormal_fertilization | 3.09480544 |
8 | MP0002139_abnormal_hepatobiliary_system | 3.01716361 |
9 | MP0004859_abnormal_synaptic_plasticity | 2.84793988 |
10 | MP0004130_abnormal_muscle_cell | 2.75660315 |
11 | MP0002332_abnormal_exercise_endurance | 2.49521228 |
12 | MP0004036_abnormal_muscle_relaxation | 2.41500118 |
13 | MP0004270_analgesia | 2.26187704 |
14 | MP0005360_urolithiasis | 2.08667267 |
15 | MP0005085_abnormal_gallbladder_physiolo | 2.07637506 |
16 | MP0009780_abnormal_chondrocyte_physiolo | 1.97209583 |
17 | MP0000747_muscle_weakness | 1.92020486 |
18 | MP0003195_calcinosis | 1.91225778 |
19 | MP0000733_abnormal_muscle_development | 1.89157116 |
20 | MP0008438_abnormal_cutaneous_collagen | 1.82398405 |
21 | MP0005620_abnormal_muscle_contractility | 1.78851491 |
22 | MP0003635_abnormal_synaptic_transmissio | 1.78800106 |
23 | MP0004087_abnormal_muscle_fiber | 1.73928850 |
24 | MP0004215_abnormal_myocardial_fiber | 1.69130986 |
25 | MP0003252_abnormal_bile_duct | 1.68292909 |
26 | MP0002106_abnormal_muscle_physiology | 1.66823760 |
27 | MP0000759_abnormal_skeletal_muscle | 1.66106001 |
28 | MP0005409_darkened_coat_color | 1.64311021 |
29 | MP0005365_abnormal_bile_salt | 1.63461548 |
30 | MP0002876_abnormal_thyroid_physiology | 1.60361542 |
31 | MP0003950_abnormal_plasma_membrane | 1.57233084 |
32 | MP0005670_abnormal_white_adipose | 1.55029914 |
33 | MP0004084_abnormal_cardiac_muscle | 1.54047066 |
34 | MP0009745_abnormal_behavioral_response | 1.50031767 |
35 | MP0003828_pulmonary_edema | 1.48706842 |
36 | MP0003705_abnormal_hypodermis_morpholog | 1.48702076 |
37 | MP0005666_abnormal_adipose_tissue | 1.48007141 |
38 | MP0002127_abnormal_cardiovascular_syste | 1.47902147 |
39 | MP0002269_muscular_atrophy | 1.47548936 |
40 | MP0003880_abnormal_central_pattern | 1.45988035 |
41 | MP0002909_abnormal_adrenal_gland | 1.44772346 |
42 | MP0005369_muscle_phenotype | 1.41780775 |
43 | MP0002735_abnormal_chemical_nociception | 1.41676276 |
44 | MP0005330_cardiomyopathy | 1.39034314 |
45 | MP0003221_abnormal_cardiomyocyte_apopto | 1.35248980 |
46 | MP0009046_muscle_twitch | 1.35227039 |
47 | MP0008569_lethality_at_weaning | 1.33230373 |
48 | MP0003868_abnormal_feces_composition | 1.31543120 |
49 | MP0004484_altered_response_of | 1.30403989 |
50 | MP0002822_catalepsy | 1.26064733 |
51 | MP0004043_abnormal_pH_regulation | 1.25440137 |
52 | MP0003879_abnormal_hair_cell | 1.25279379 |
53 | MP0002063_abnormal_learning/memory/cond | 1.22882120 |
54 | MP0010329_abnormal_lipoprotein_level | 1.22441231 |
55 | MP0001968_abnormal_touch/_nociception | 1.20945194 |
56 | MP0001188_hyperpigmentation | 1.20794948 |
57 | MP0002972_abnormal_cardiac_muscle | 1.19367522 |
58 | MP0003136_yellow_coat_color | 1.18555699 |
59 | MP0002272_abnormal_nervous_system | 1.18537414 |
60 | MP0002064_seizures | 1.17005197 |
61 | MP0000013_abnormal_adipose_tissue | 1.14231840 |
62 | MP0008875_abnormal_xenobiotic_pharmacok | 1.13729985 |
63 | MP0005266_abnormal_metabolism | 1.12967976 |
64 | MP0002971_abnormal_brown_adipose | 1.12275635 |
65 | MP0000003_abnormal_adipose_tissue | 1.11645273 |
66 | MP0003698_abnormal_male_reproductive | 1.11617394 |
67 | MP0005535_abnormal_body_temperature | 1.10654147 |
68 | MP0003045_fibrosis | 1.10486837 |
69 | MP0005375_adipose_tissue_phenotype | 1.08503914 |
70 | MP0002078_abnormal_glucose_homeostasis | 1.07574861 |
71 | MP0004085_abnormal_heartbeat | 1.05940533 |
72 | MP0005275_abnormal_skin_tensile | 1.05243456 |
73 | MP0002734_abnormal_mechanical_nocicepti | 1.04902453 |
74 | MP0003656_abnormal_erythrocyte_physiolo | 1.04622706 |
75 | MP0003137_abnormal_impulse_conducting | 1.04451417 |
76 | MP0004233_abnormal_muscle_weight | 1.03410931 |
77 | MP0002067_abnormal_sensory_capabilities | 1.03044319 |
78 | MP0003633_abnormal_nervous_system | 1.02240706 |
79 | MP0001486_abnormal_startle_reflex | 1.02015979 |
80 | MP0009840_abnormal_foam_cell | 0.99838017 |
81 | MP0002118_abnormal_lipid_homeostasis | 0.98800705 |
82 | MP0001765_abnormal_ion_homeostasis | 0.97609340 |
83 | MP0002572_abnormal_emotion/affect_behav | 0.97294029 |
84 | MP0005332_abnormal_amino_acid | 0.95704967 |
85 | MP0002108_abnormal_muscle_morphology | 0.93524266 |
86 | MP0002557_abnormal_social/conspecific_i | 0.86217514 |
87 | MP0005623_abnormal_meninges_morphology | 0.85296851 |
88 | MP0005334_abnormal_fat_pad | 0.84789320 |
89 | MP0006036_abnormal_mitochondrial_physio | 0.84016568 |
90 | MP0008874_decreased_physiological_sensi | 0.83225511 |
91 | MP0000750_abnormal_muscle_regeneration | 0.82841430 |
92 | MP0008775_abnormal_heart_ventricle | 0.82627918 |
93 | MP0004147_increased_porphyrin_level | 0.81774709 |
94 | MP0002138_abnormal_hepatobiliary_system | 0.81548593 |
95 | MP0006138_congestive_heart_failure | 0.81398434 |
96 | MP0002009_preneoplasia | 0.80820558 |
97 | MP0005171_absent_coat_pigmentation | 0.79521839 |
98 | MP0004185_abnormal_adipocyte_glucose | 0.78826249 |
99 | MP0001544_abnormal_cardiovascular_syste | 0.77721287 |
100 | MP0005385_cardiovascular_system_phenoty | 0.77721287 |
101 | MP0008961_abnormal_basal_metabolism | 0.77713868 |
102 | MP0001970_abnormal_pain_threshold | 0.76899906 |
103 | MP0000266_abnormal_heart_morphology | 0.75574766 |
104 | MP0000372_irregular_coat_pigmentation | 0.75529430 |
105 | MP0005165_increased_susceptibility_to | 0.75207757 |
106 | MP0000230_abnormal_systemic_arterial | 0.73391856 |
107 | MP0003566_abnormal_cell_adhesion | 0.73053256 |
108 | MP0002896_abnormal_bone_mineralization | 0.72856889 |
109 | MP0002733_abnormal_thermal_nociception | 0.72600600 |
110 | MP0004272_abnormal_basement_membrane | 0.72369206 |
111 | MP0010630_abnormal_cardiac_muscle | 0.72254076 |
112 | MP0005167_abnormal_blood-brain_barrier | 0.71683085 |
113 | MP0003279_aneurysm | 0.71677060 |
114 | MP0008260_abnormal_autophagy | 0.71497247 |
115 | MP0001661_extended_life_span | 0.68465388 |
116 | MP0004510_myositis | 0.67854870 |
117 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.66086041 |
118 | MP0010368_abnormal_lymphatic_system | 0.65640132 |
119 | MP0003329_amyloid_beta_deposits | 0.65225257 |
120 | MP0002128_abnormal_blood_circulation | 0.63193199 |
121 | MP0005503_abnormal_tendon_morphology | 0.62987780 |
122 | MP0008004_abnormal_stomach_pH | 0.60346203 |
123 | MP0003191_abnormal_cellular_cholesterol | 0.59690367 |
124 | MP0001958_emphysema | 0.59690079 |
125 | MP0005083_abnormal_biliary_tract | 0.59386687 |
126 | MP0003941_abnormal_skin_development | 0.58238528 |
127 | MP0002877_abnormal_melanocyte_morpholog | 0.54356798 |
128 | MP0004134_abnormal_chest_morphology | 0.53066133 |
129 | MP0001299_abnormal_eye_distance/ | 0.52871122 |
130 | MP0000343_altered_response_to | 0.48462360 |
131 | MP0003091_abnormal_cell_migration | 0.47222561 |
132 | MP0005166_decreased_susceptibility_to | 0.44374431 |
133 | MP0002168_other_aberrant_phenotype | 0.43015780 |
134 | MP0005376_homeostasis/metabolism_phenot | 0.41189256 |
135 | MP0009384_cardiac_valve_regurgitation | 0.37260837 |
136 | MP0000767_abnormal_smooth_muscle | 0.35013825 |
137 | MP0000762_abnormal_tongue_morphology | 0.34940834 |
138 | MP0005023_abnormal_wound_healing | 0.33276342 |
139 | MP0005319_abnormal_enzyme/_coenzyme | 0.32686940 |
140 | MP0003806_abnormal_nucleotide_metabolis | 0.32136394 |
141 | MP0005058_abnormal_lysosome_morphology | 0.31943411 |
142 | MP0004858_abnormal_nervous_system | 0.27726664 |
143 | MP0003959_abnormal_lean_body | 0.27672763 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Exercise-induced myalgia (HP:0003738) | 5.59322879 |
2 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.63438808 |
3 | Exercise-induced muscle cramps (HP:0003710) | 4.46111343 |
4 | Calf muscle hypertrophy (HP:0008981) | 4.45803935 |
5 | Muscle fiber inclusion bodies (HP:0100299) | 4.45787075 |
6 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.32041150 |
7 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.24491728 |
8 | Neck muscle weakness (HP:0000467) | 4.15891484 |
9 | Hyporeflexia of lower limbs (HP:0002600) | 3.97067906 |
10 | Type 1 muscle fiber predominance (HP:0003803) | 3.94191523 |
11 | Distal lower limb muscle weakness (HP:0009053) | 3.85711152 |
12 | Rimmed vacuoles (HP:0003805) | 3.76737333 |
13 | Sudden death (HP:0001699) | 3.75773757 |
14 | Absent/shortened dynein arms (HP:0200106) | 3.72432031 |
15 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.72432031 |
16 | Difficulty running (HP:0009046) | 3.67360799 |
17 | Myoglobinuria (HP:0002913) | 3.62434954 |
18 | Focal motor seizures (HP:0011153) | 3.59059334 |
19 | Nemaline bodies (HP:0003798) | 3.57342816 |
20 | Muscle fiber splitting (HP:0003555) | 3.43207220 |
21 | Calcaneovalgus deformity (HP:0001848) | 3.42330308 |
22 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.30319686 |
23 | Frequent falls (HP:0002359) | 3.25533453 |
24 | Abnormality of the calf musculature (HP:0001430) | 3.20553898 |
25 | EMG: myopathic abnormalities (HP:0003458) | 3.20246576 |
26 | Increased variability in muscle fiber diameter (HP:0003557) | 3.17772753 |
27 | Agitation (HP:0000713) | 3.07750808 |
28 | Distal arthrogryposis (HP:0005684) | 3.06476993 |
29 | Hyperkalemia (HP:0002153) | 2.99964031 |
30 | Deformed tarsal bones (HP:0008119) | 2.98834456 |
31 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.94854048 |
32 | Areflexia of lower limbs (HP:0002522) | 2.85047418 |
33 | Myotonia (HP:0002486) | 2.81378471 |
34 | Asymmetric septal hypertrophy (HP:0001670) | 2.76982920 |
35 | Muscle stiffness (HP:0003552) | 2.74986162 |
36 | Bundle branch block (HP:0011710) | 2.74560567 |
37 | Testicular atrophy (HP:0000029) | 2.70345020 |
38 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.63914681 |
39 | Subaortic stenosis (HP:0001682) | 2.63914681 |
40 | Malignant hyperthermia (HP:0002047) | 2.62903135 |
41 | Increased connective tissue (HP:0009025) | 2.61354036 |
42 | Scapular winging (HP:0003691) | 2.54583908 |
43 | Hypercortisolism (HP:0001578) | 2.53743301 |
44 | Action tremor (HP:0002345) | 2.53637112 |
45 | Spinal rigidity (HP:0003306) | 2.51336267 |
46 | Dysmetric saccades (HP:0000641) | 2.49929180 |
47 | Limb-girdle muscle atrophy (HP:0003797) | 2.48019639 |
48 | Ketoacidosis (HP:0001993) | 2.47128612 |
49 | Generalized muscle weakness (HP:0003324) | 2.47111794 |
50 | Ketosis (HP:0001946) | 2.44659613 |
51 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.44617862 |
52 | Round ear (HP:0100830) | 2.39502598 |
53 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.37093737 |
54 | Myopathic facies (HP:0002058) | 2.36117963 |
55 | Depression (HP:0000716) | 2.35768584 |
56 | Gaze-evoked nystagmus (HP:0000640) | 2.35602568 |
57 | Hypoglycemic coma (HP:0001325) | 2.33446373 |
58 | Atrial fibrillation (HP:0005110) | 2.32670129 |
59 | Ventricular arrhythmia (HP:0004308) | 2.31150929 |
60 | Slender build (HP:0001533) | 2.29746529 |
61 | Gowers sign (HP:0003391) | 2.27922518 |
62 | Nonprogressive disorder (HP:0003680) | 2.27647667 |
63 | Abnormality of the foot musculature (HP:0001436) | 2.26280493 |
64 | Late onset (HP:0003584) | 2.26199911 |
65 | Difficulty climbing stairs (HP:0003551) | 2.23312286 |
66 | Focal seizures (HP:0007359) | 2.20280377 |
67 | Foot dorsiflexor weakness (HP:0009027) | 2.19660077 |
68 | Ventricular tachycardia (HP:0004756) | 2.18707088 |
69 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.16364930 |
70 | Atrioventricular block (HP:0001678) | 2.14781933 |
71 | Syncope (HP:0001279) | 2.13323507 |
72 | Primary atrial arrhythmia (HP:0001692) | 2.13011387 |
73 | Progressive muscle weakness (HP:0003323) | 2.10427962 |
74 | Rhabdomyolysis (HP:0003201) | 2.10059221 |
75 | Heart block (HP:0012722) | 2.09304536 |
76 | Impaired proprioception (HP:0010831) | 2.08912788 |
77 | Fetal akinesia sequence (HP:0001989) | 2.06271466 |
78 | Hypoalphalipoproteinemia (HP:0003233) | 2.05653173 |
79 | Infertility (HP:0000789) | 2.03676631 |
80 | Weak cry (HP:0001612) | 2.02599750 |
81 | Abnormality of the calcaneus (HP:0008364) | 2.02589470 |
82 | Right ventricular cardiomyopathy (HP:0011663) | 2.02330772 |
83 | Prolonged QT interval (HP:0001657) | 2.01042060 |
84 | Lower limb hyperreflexia (HP:0002395) | 2.00768212 |
85 | Myokymia (HP:0002411) | 2.00570840 |
86 | Anxiety (HP:0000739) | 2.00538477 |
87 | Hip contracture (HP:0003273) | 1.99213837 |
88 | EMG: neuropathic changes (HP:0003445) | 1.97861052 |
89 | Abnormal atrioventricular conduction (HP:0005150) | 1.97298935 |
90 | Prolonged partial thromboplastin time (HP:0003645) | 1.93777644 |
91 | Supraventricular tachycardia (HP:0004755) | 1.91538314 |
92 | Progressive cerebellar ataxia (HP:0002073) | 1.91452218 |
93 | Hyperglycinuria (HP:0003108) | 1.90130677 |
94 | Fatigable weakness (HP:0003473) | 1.89616442 |
95 | Abnormality of the neuromuscular junction (HP:0003398) | 1.89616442 |
96 | Febrile seizures (HP:0002373) | 1.89033957 |
97 | Lipoatrophy (HP:0100578) | 1.88677852 |
98 | Dilated cardiomyopathy (HP:0001644) | 1.88155210 |
99 | Deep venous thrombosis (HP:0002625) | 1.87849563 |
100 | Supraventricular arrhythmia (HP:0005115) | 1.87785165 |
101 | Abnormal ciliary motility (HP:0012262) | 1.86433680 |
102 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.86103857 |
103 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.86103857 |
104 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.86062500 |
105 | Cholelithiasis (HP:0001081) | 1.84369711 |
106 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.83385221 |
107 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.82935887 |
108 | Absent phalangeal crease (HP:0006109) | 1.82155149 |
109 | Termporal pattern (HP:0011008) | 1.81859671 |
110 | Insidious onset (HP:0003587) | 1.81859671 |
111 | Abnormal finger flexion creases (HP:0006143) | 1.81726435 |
112 | Visual hallucinations (HP:0002367) | 1.80780555 |
113 | Bulbar palsy (HP:0001283) | 1.80028538 |
114 | Ulnar deviation of the wrist (HP:0003049) | 1.79527088 |
115 | Broad-based gait (HP:0002136) | 1.79436557 |
116 | Impaired vibratory sensation (HP:0002495) | 1.78942123 |
117 | Ragged-red muscle fibers (HP:0003200) | 1.78472047 |
118 | Popliteal pterygium (HP:0009756) | 1.78267099 |
119 | Hyperglycemia (HP:0003074) | 1.77726883 |
120 | Restlessness (HP:0000711) | 1.76412589 |
121 | Proximal amyotrophy (HP:0007126) | 1.75616078 |
122 | Hyperglycinemia (HP:0002154) | 1.75074525 |
123 | Distal lower limb amyotrophy (HP:0008944) | 1.75041104 |
124 | Genetic anticipation (HP:0003743) | 1.74846135 |
125 | Generalized tonic-clonic seizures (HP:0002069) | 1.74267050 |
126 | Lower limb amyotrophy (HP:0007210) | 1.73628631 |
127 | Muscular dystrophy (HP:0003560) | 1.73591993 |
128 | Abnormal gallbladder morphology (HP:0012437) | 1.72302514 |
129 | Facial diplegia (HP:0001349) | 1.71520012 |
130 | Limb-girdle muscle weakness (HP:0003325) | 1.70095956 |
131 | Rhinitis (HP:0012384) | 1.69887993 |
132 | Waddling gait (HP:0002515) | 1.69205682 |
133 | Ventricular fibrillation (HP:0001663) | 1.66936085 |
134 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.65235374 |
135 | Metatarsus adductus (HP:0001840) | 1.60637168 |
136 | Achilles tendon contracture (HP:0001771) | 1.54579586 |
137 | Pelvic girdle muscle weakness (HP:0003749) | 1.53462219 |
138 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.52816421 |
139 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.52816421 |
140 | Abnormality of the Achilles tendon (HP:0005109) | 1.52143517 |
141 | Palpitations (HP:0001962) | 1.51716832 |
142 | Protrusio acetabuli (HP:0003179) | 1.51045038 |
143 | Long clavicles (HP:0000890) | 1.47710021 |
144 | Limited hip movement (HP:0008800) | 1.46468657 |
145 | Paralysis (HP:0003470) | 1.45098132 |
146 | Back pain (HP:0003418) | 1.44280098 |
147 | Shoulder girdle muscle weakness (HP:0003547) | 1.44204293 |
148 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.43632305 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PDK3 | 3.58104542 |
2 | PDK4 | 3.58104542 |
3 | PRKD3 | 3.06219649 |
4 | OBSCN | 3.02900876 |
5 | PHKG1 | 2.56922431 |
6 | PHKG2 | 2.56922431 |
7 | INSRR | 2.42076750 |
8 | TTN | 2.23922964 |
9 | CASK | 2.21186076 |
10 | PDK2 | 2.11285779 |
11 | PINK1 | 2.09963732 |
12 | NTRK3 | 2.08932647 |
13 | STK38 | 2.06289075 |
14 | DAPK2 | 1.96972330 |
15 | TRPM7 | 1.87820143 |
16 | EPHA4 | 1.87382501 |
17 | NEK9 | 1.86093684 |
18 | MAP2K3 | 1.67897445 |
19 | PTK2B | 1.61865993 |
20 | MAPKAPK3 | 1.61683969 |
21 | MAPK12 | 1.61648050 |
22 | MAP2K4 | 1.58890889 |
23 | WNK4 | 1.57718597 |
24 | PRKD2 | 1.54975737 |
25 | EEF2K | 1.52322941 |
26 | MYLK | 1.37282851 |
27 | MAP2K7 | 1.35740996 |
28 | MAPK13 | 1.34624489 |
29 | TNIK | 1.33548862 |
30 | MUSK | 1.29970058 |
31 | DMPK | 1.27335779 |
32 | LMTK2 | 1.25046826 |
33 | MAP3K7 | 1.23924320 |
34 | NEK1 | 1.22956987 |
35 | MAP3K4 | 1.21671684 |
36 | LATS2 | 1.20044128 |
37 | PRPF4B | 1.18171311 |
38 | FER | 1.17443350 |
39 | SGK2 | 1.16509392 |
40 | BCKDK | 1.15264550 |
41 | FES | 1.12498679 |
42 | WNK1 | 1.11846682 |
43 | CAMKK1 | 1.08253181 |
44 | CAMK1 | 1.06071860 |
45 | TRIB3 | 1.05068848 |
46 | PIK3CG | 1.04734952 |
47 | SGK3 | 1.03842770 |
48 | PAK6 | 0.97659363 |
49 | MOS | 0.96851042 |
50 | SGK494 | 0.96356375 |
51 | SGK223 | 0.96356375 |
52 | SIK1 | 0.95171085 |
53 | CAMK1G | 0.94250243 |
54 | RIPK4 | 0.93756070 |
55 | FRK | 0.91831810 |
56 | STK39 | 0.89962387 |
57 | CCNB1 | 0.89830518 |
58 | ROCK1 | 0.89082798 |
59 | MAPK11 | 0.88135394 |
60 | PRKAA1 | 0.87366768 |
61 | CAMKK2 | 0.86450554 |
62 | PDK1 | 0.85785082 |
63 | PRKAA2 | 0.84074324 |
64 | TIE1 | 0.83907547 |
65 | MAP2K1 | 0.83510856 |
66 | ICK | 0.83483874 |
67 | LIMK1 | 0.83421842 |
68 | MAP3K1 | 0.82974062 |
69 | MAP3K13 | 0.82089693 |
70 | PDGFRA | 0.81553085 |
71 | PDPK1 | 0.81433245 |
72 | NTRK1 | 0.81008734 |
73 | MINK1 | 0.80025860 |
74 | GRK5 | 0.79644380 |
75 | STK11 | 0.78633479 |
76 | ERBB3 | 0.78408796 |
77 | SCYL2 | 0.77209611 |
78 | CAMK2A | 0.76729230 |
79 | LATS1 | 0.76040283 |
80 | PRKCH | 0.75171937 |
81 | KSR2 | 0.71283026 |
82 | TESK1 | 0.69441941 |
83 | SGK1 | 0.69277271 |
84 | MAP3K5 | 0.69237807 |
85 | RET | 0.68486372 |
86 | DAPK3 | 0.67827977 |
87 | ARAF | 0.66868108 |
88 | MAPK7 | 0.66400076 |
89 | MAP3K2 | 0.66317907 |
90 | MAPK15 | 0.65252382 |
91 | PRKD1 | 0.64617667 |
92 | RAF1 | 0.63968343 |
93 | CDK5 | 0.63582072 |
94 | IRAK3 | 0.62770912 |
95 | AKT3 | 0.62600156 |
96 | PIK3CA | 0.62135538 |
97 | TNK2 | 0.61482597 |
98 | AKT2 | 0.61128381 |
99 | MAP2K6 | 0.59644973 |
100 | ERN1 | 0.57072377 |
101 | MAPK4 | 0.56937561 |
102 | PRKCG | 0.54675821 |
103 | TBK1 | 0.53248558 |
104 | TAOK2 | 0.53215211 |
105 | FGFR2 | 0.51904415 |
106 | PKN2 | 0.51576400 |
107 | MAP3K12 | 0.51465365 |
108 | MAP3K3 | 0.50443214 |
109 | MARK1 | 0.49895343 |
110 | MST1R | 0.48782957 |
111 | HIPK2 | 0.48490548 |
112 | PAK3 | 0.48481339 |
113 | MARK2 | 0.47917974 |
114 | EIF2AK1 | 0.46719050 |
115 | MAP3K6 | 0.45860970 |
116 | CAMK4 | 0.45716621 |
117 | CAMK2G | 0.45361329 |
118 | CAMK2D | 0.45193308 |
119 | JAK2 | 0.45010734 |
120 | TGFBR2 | 0.44845486 |
121 | MTOR | 0.44712333 |
122 | NME1 | 0.44627825 |
123 | RIPK1 | 0.44495248 |
124 | CAMK2B | 0.43976304 |
125 | IRAK2 | 0.43086824 |
126 | UHMK1 | 0.42438519 |
127 | PRKACA | 0.42231722 |
128 | DDR2 | 0.41147265 |
129 | MET | 0.40901104 |
130 | NTRK2 | 0.40766676 |
131 | KSR1 | 0.40477902 |
132 | RPS6KA3 | 0.39921395 |
133 | PRKACG | 0.37760309 |
134 | MAPK10 | 0.37191669 |
135 | PRKCZ | 0.36755789 |
136 | PRKG1 | 0.36123320 |
137 | DYRK1B | 0.36112151 |
138 | JAK1 | 0.35564131 |
139 | TAOK1 | 0.34694786 |
140 | SIK2 | 0.34348464 |
141 | CDC42BPA | 0.33882767 |
142 | PAK2 | 0.29424386 |
143 | ROCK2 | 0.29142174 |
144 | PTK2 | 0.27894124 |
145 | RPS6KB1 | 0.26191701 |
146 | PKN1 | 0.21167078 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88677068 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.84426755 |
3 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.74349675 |
4 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.74119252 |
5 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.71383636 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.69961425 |
7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.69008989 |
8 | Insulin secretion_Homo sapiens_hsa04911 | 1.67696939 |
9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.54733382 |
10 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.53028613 |
11 | Circadian entrainment_Homo sapiens_hsa04713 | 1.42368658 |
12 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.41728141 |
13 | Long-term potentiation_Homo sapiens_hsa04720 | 1.39352948 |
14 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.37003423 |
15 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.36154491 |
16 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.34866467 |
17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.34212888 |
18 | Salivary secretion_Homo sapiens_hsa04970 | 1.33573365 |
19 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.33481371 |
20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.32779055 |
21 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.32475156 |
22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.32162056 |
23 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.31866634 |
24 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.29939562 |
25 | Renin secretion_Homo sapiens_hsa04924 | 1.28233668 |
26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.27530415 |
27 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.26064508 |
28 | Olfactory transduction_Homo sapiens_hsa04740 | 1.25920255 |
29 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.25186737 |
30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.24921931 |
31 | Morphine addiction_Homo sapiens_hsa05032 | 1.23290495 |
32 | Focal adhesion_Homo sapiens_hsa04510 | 1.20829121 |
33 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.20109337 |
34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.19843608 |
35 | Bile secretion_Homo sapiens_hsa04976 | 1.19538028 |
36 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.18625705 |
37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18235192 |
38 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.18207482 |
39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.17074118 |
40 | Nicotine addiction_Homo sapiens_hsa05033 | 1.13328923 |
41 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13219909 |
42 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.12801199 |
43 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.12414358 |
44 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.10525714 |
45 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.09387265 |
46 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.09332330 |
47 | GABAergic synapse_Homo sapiens_hsa04727 | 1.08485325 |
48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.08043882 |
49 | Taste transduction_Homo sapiens_hsa04742 | 1.06969404 |
50 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.03704261 |
51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.03571938 |
52 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.02496285 |
53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.01878464 |
54 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.99784572 |
55 | ABC transporters_Homo sapiens_hsa02010 | 0.98527567 |
56 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.97900023 |
57 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.97049205 |
58 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.96862546 |
59 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96769927 |
60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.96346217 |
61 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.94857800 |
62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93595099 |
63 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.88816246 |
64 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.88507480 |
65 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.88465599 |
66 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.88338813 |
67 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.88231696 |
68 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.87508035 |
69 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.83851146 |
70 | Amoebiasis_Homo sapiens_hsa05146 | 0.83202984 |
71 | Tight junction_Homo sapiens_hsa04530 | 0.83165247 |
72 | Insulin resistance_Homo sapiens_hsa04931 | 0.83034126 |
73 | Circadian rhythm_Homo sapiens_hsa04710 | 0.82130541 |
74 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79843249 |
75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.79003711 |
76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78907151 |
77 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.78714743 |
78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.78314642 |
79 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.77786870 |
80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.76516186 |
81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76102539 |
82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76083692 |
83 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.75131043 |
84 | Long-term depression_Homo sapiens_hsa04730 | 0.74320955 |
85 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.74015003 |
86 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.72638973 |
87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71115296 |
88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.70534922 |
89 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.70275526 |
90 | Peroxisome_Homo sapiens_hsa04146 | 0.70108319 |
91 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.69841337 |
92 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.67975045 |
93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.64104615 |
94 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.64067629 |
95 | Melanogenesis_Homo sapiens_hsa04916 | 0.63663326 |
96 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62538881 |
97 | Carbon metabolism_Homo sapiens_hsa01200 | 0.62485011 |
98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62117262 |
99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.58830732 |
100 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.58362572 |
101 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.57973676 |
102 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57288630 |
103 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56724307 |
104 | Adherens junction_Homo sapiens_hsa04520 | 0.55258072 |
105 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.53968476 |
106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53579132 |
107 | Alzheimers disease_Homo sapiens_hsa05010 | 0.53101867 |
108 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52860402 |
109 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.52595226 |
110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51758718 |
111 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51655820 |
112 | Phototransduction_Homo sapiens_hsa04744 | 0.51437138 |
113 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50909600 |
114 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50496870 |
115 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.50468236 |
116 | Prion diseases_Homo sapiens_hsa05020 | 0.49954020 |
117 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.49428084 |
118 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49324213 |
119 | Lysine degradation_Homo sapiens_hsa00310 | 0.48124930 |
120 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47346829 |
121 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47159784 |
122 | Gap junction_Homo sapiens_hsa04540 | 0.45495719 |
123 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44803519 |
124 | Platelet activation_Homo sapiens_hsa04611 | 0.44554678 |
125 | Cocaine addiction_Homo sapiens_hsa05030 | 0.43626431 |
126 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.42415015 |
127 | Glioma_Homo sapiens_hsa05214 | 0.41688697 |
128 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.36834024 |
129 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.36376045 |
130 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33860065 |
131 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.32043832 |
132 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31463707 |
133 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30887475 |
134 | Thyroid cancer_Homo sapiens_hsa05216 | 0.28079940 |
135 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.27987475 |
136 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.26340724 |
137 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26325400 |